Please assess the completion status of the following clinical trial:

Trial Title: Immunogenicity of a Reduced Primary Schedule for Pneumococcal Conjugate Vaccine in UK Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Informed consent by parent/guardian for receipt of study vaccines and for blood samples~* Age at first dose: Infants 7-11 weeks; toddlers 12-18 months~Exclusion Criteria:~* Previous bacteriologically confirmed pneumococcal or meningococcal disease~* Contraindications for pneumococcal, meningococcal, Hib, DTP, MMR immunisations as listed in the UK handbook, Immunisation Against Infectious Disease Edition 1996.~* Language difficulty in parents sufficient to preclude adequate comprehension of the information sheet, consent form and study nurses' explanation of the study~* Children participating in any other clinical trial~* Immunocompromised~* Acute systemic illness or fever \> 38C on day of vaccination - deferral

- Gender: ALL
- Minimum Age: 7 Weeks
- Maximum Age: 18 Months
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).